We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
117 hedge funds and large institutions have $679M invested in Accelerate Diagnostics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 24
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more capital invested
Capital invested by funds: $579M → $679M (+$99.4M)
3% more funds holding
Funds holding: 114 → 117 (+3)
8% more call options, than puts
Call options by funds: $10.2M | Put options by funds: $9.47M
Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
2.54%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
18
Increased
38
Reduced
24
Closed
12
Calls
$10.2M
Puts
$9.47M
Net Calls
+$734K
Net Calls Change
-$3.54M
Top Buyers
| 1 |
Axa
Paris,
France
|
+$25.9M |
| 2 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$8.02M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.12M |
| 4 |
BlackRock
New York
|
+$5.23M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.24M |
